1. Home
  2. NLSP vs CVR Comparison

NLSP vs CVR Comparison

Compare NLSP & CVR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NLSP
  • CVR
  • Stock Information
  • Founded
  • NLSP 2015
  • CVR 1920
  • Country
  • NLSP Switzerland
  • CVR United States
  • Employees
  • NLSP N/A
  • CVR N/A
  • Industry
  • NLSP Biotechnology: Pharmaceutical Preparations
  • CVR Industrial Machinery/Components
  • Sector
  • NLSP Health Care
  • CVR Industrials
  • Exchange
  • NLSP Nasdaq
  • CVR Nasdaq
  • Market Cap
  • NLSP 12.4M
  • CVR 11.1M
  • IPO Year
  • NLSP 2021
  • CVR N/A
  • Fundamental
  • Price
  • NLSP $2.68
  • CVR $12.40
  • Analyst Decision
  • NLSP
  • CVR
  • Analyst Count
  • NLSP 0
  • CVR 0
  • Target Price
  • NLSP N/A
  • CVR N/A
  • AVG Volume (30 Days)
  • NLSP 325.4K
  • CVR 2.7K
  • Earning Date
  • NLSP 07-07-2025
  • CVR 08-12-2025
  • Dividend Yield
  • NLSP N/A
  • CVR 0.93%
  • EPS Growth
  • NLSP N/A
  • CVR N/A
  • EPS
  • NLSP N/A
  • CVR N/A
  • Revenue
  • NLSP N/A
  • CVR $26,379,081.00
  • Revenue This Year
  • NLSP N/A
  • CVR N/A
  • Revenue Next Year
  • NLSP N/A
  • CVR N/A
  • P/E Ratio
  • NLSP N/A
  • CVR N/A
  • Revenue Growth
  • NLSP N/A
  • CVR N/A
  • 52 Week Low
  • NLSP $1.30
  • CVR $8.15
  • 52 Week High
  • NLSP $16.00
  • CVR $22.27
  • Technical
  • Relative Strength Index (RSI)
  • NLSP 62.59
  • CVR 47.50
  • Support Level
  • NLSP $2.19
  • CVR $11.70
  • Resistance Level
  • NLSP $2.54
  • CVR $13.90
  • Average True Range (ATR)
  • NLSP 0.19
  • CVR 0.69
  • MACD
  • NLSP -0.01
  • CVR -0.22
  • Stochastic Oscillator
  • NLSP 57.89
  • CVR 29.39

About NLSP NLS Pharmaceutics Ltd.

NLS Pharmaceutics Ltd a clinical-stage biopharmaceutical company focused on the discovery and development of inventive therapies for patients with rare and complex CNS disorders with unmet medical needs. Its compound, mazindol, a triple monoamine reuptake inhibitor and partial orexin receptor 2 agonist, in a proprietary ER formulation, is being developed for the treatment of narcolepsy, IH (follow-on indication), and potentially ADHD (back-up indication). Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.

About CVR Chicago Rivet & Machine Co.

Chicago Rivet & Machine Co is in the fastener industry in North America. The company operates in two segments namely fasteners and assembly equipment. Its fastener segment consists of the manufacture and sale of rivets, cold-formed fasteners, parts, and screw machine products. The assembly equipment segment consists mainly of the manufacture of automatic rivet setting machines, automatic assembly equipment, and parts and tools for such machines. The majority of revenue is from the fastener segment.

Share on Social Networks: